Abiopharma

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025

IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025